Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases

NCT01884311 is registered in ClinicalTrials.gov with Bio Products Laboratory as lead sponsor.

NCT NCT01884311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01884311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Lead sponsor
Bio Products Laboratory
Phase
Phase 3
Overall status
Completed
Start date
August 20, 2015
Completion date
May 25, 2017
Enrollment
38 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

common variable immunodeficiency, hyperimmunoglobulin m syndrome, primary immune deficiency disorders, x-linked agammaglobulinaemia